Table 3.
Multivariate analysis of variables associated with in-hospital mortality in patients with STEMI
| Variables | Survivors (n = 35) | Non-survivors (n = 120) | P value | AOR (95% CI) |
|---|---|---|---|---|
| Age ≥ 65 year, n (%) | 151 (42.7) | 97 (80.8) | < 0.001 | 4.668 (2.684–8.117) |
| Male, n (%) | 256 (72.3) | 71(59.2) | 0.542 | 0.848 (0.498–1.441) |
| DM, n (%) | 64 (25.4) | 45 (37.5) | 0.610 | 1.161 (0.654–2.062) |
| Smoking, n (%) | 212 (59.9) | 58 (48.3) | 0.864 | 1.046 (0.627–1.743) |
| FPG ≥ 6.1 mmol/L, n (%) | 154 (43.5) | 76 (63.3) | 0.005 | 2.010 (1.236–3.267) |
| TG ≥ 1.8 mmol/L, n (%) | 134 (37.9) | 31 (25.8) | 0.208 | 0.699 (0.400–1.221) |
| TC ≥ 6.6 mmol/L, n (%) | 19 (5.4) | 5 (4.2) | 0.930 | 0.948 (0.288–3.117) |
| AST ≥ 2 ULN, n (%) | 230 (65.0) | 76 (63.3) | 0.529 | 0.832 (0.470–1.474) |
| ALT ≥ 2 ULN, n (%) | 74 (15.6) | 27 (22.5) | 0.041 | 1.915 (1.028–3.565) |
| GGT ≥ 2 ULN, n (%) | 35 (0.9) | 18 (15.0) | 0.287 | 1.502 (0.710–3.178) |
| DD ≥ 400 ng/mL, n (%) | 103 (29.1) | 75 (62.5) | 0.010 | 1.937 (1.170–3.194) |
| Tn I ≥ 2.5 ng/mL, n (%) | 201 (56.8) | 77 (64.2) | 0.952 | 0.984 (0.572–1.692) |
| Fib ≥ 3.5 g/L, n (%) | 163 (46.0) | 76 (63.3) | 0.017 | 1.810 (1.113–2.944) |
| eGFR (mL/min/1.73 m2) < 90, n (%) | 95 (26.8) | 70 (58.3) | 0.017 | 1.834 (1.112–3.023) |
Age, sex, DM, smoking history, FPG, TC, triglycerides, AST, ALT, GGT, Tn I, D-dimer, fibrinogen, and eGFR were included in the multivariate logistic regression analysis
ALT, alanine aminotransferase; AOR, adjusted odds ratio; AST, aspartate aminotransferase; CI, confidence interval; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; FPG, fasting plasma glucose; GGT, γ-glutamyl transpeptidase; NSTEMI, non–ST-segment elevation myocardial infarction; STEMI, ST-segment elevation myocardial infarction; T-Bil, total bilirubin; TC, total cholesterol; Tn I, cardiac troponin I; ULN, upper limit of normal